• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胺碘酮的甲状腺作用:临床更新。

Thyroid effects of amiodarone: clinical update.

机构信息

Section of Endocrinology, Diabetes and Nutrition, Boston University School of Medicine, Boston Medical Center, Boston, Massachusetts, USA.

出版信息

Curr Opin Endocrinol Diabetes Obes. 2020 Oct;27(5):329-334. doi: 10.1097/MED.0000000000000562.

DOI:10.1097/MED.0000000000000562
PMID:32773570
Abstract

PURPOSE OF REVIEW

Amiodarone-induced thyroid dysfunction is well established and commonly encountered but is associated with several diagnostic and management challenges. The present review discusses recent evidence published related to the effects of amiodarone on the thyroid gland and thyroid function.

RECENT FINDINGS

Retrospective studies to evaluate amiodarone-induced thyroid dysfunction in children show the occurrence of potential clinically significant changes within 2 weeks of amiodarone initiation that may not be detected if standard adult guidelines for thyroid hormone monitoring are followed. A small study evaluating beta-glucuronidase activity in amiodarone-induced thyrotoxicosis (AIT) demonstrated higher levels in patients with AIT type 2 compared to type 1. New data have suggested the incidence of agranulocytosis may be higher in patients on thionamides with AIT compared to hyperthyroidism because of other causes. In a small study, investigators demonstrated the use of a combination of intravenous and oral steroids to treat refractory AIT which needs to be evaluated in further controlled trials. Finally, recent data demonstrated a possible mortality benefit of surgery over medical therapy for AIT in patients with moderate to severe reduction in left ventricular ejection fraction.

SUMMARY

Recent research regarding the prevalence, diagnosis, and management of amiodarone-induced thyroid dysfunction were reviewed.

摘要

目的综述

胺碘酮引起的甲状腺功能障碍已得到充分证实,且较为常见,但与许多诊断和管理挑战相关。本综述讨论了近期发表的与胺碘酮对甲状腺和甲状腺功能影响相关的证据。

最近的发现

评估儿童胺碘酮诱导性甲状腺功能障碍的回顾性研究显示,在开始胺碘酮治疗后 2 周内可能会发生潜在的临床显著变化,如果遵循标准的成人甲状腺激素监测指南,则可能无法检测到这些变化。一项评估胺碘酮诱导性甲状腺毒症(AIT)中β-葡糖苷酸酶活性的小型研究表明,2 型 AIT 患者的水平高于 1 型。新数据表明,与其他原因引起的甲状腺功能亢进症相比,AIT 患者使用硫脲类药物时粒细胞减少症的发生率可能更高。在一项小型研究中,研究人员证实了联合使用静脉和口服类固醇治疗难治性 AIT,这需要在进一步的对照试验中进行评估。最后,最近的数据表明,对于左心室射血分数中度至重度降低的 AIT 患者,手术治疗可能比药物治疗更有生存获益。

总结

综述了近期关于胺碘酮诱导性甲状腺功能障碍的患病率、诊断和治疗的研究进展。

相似文献

1
Thyroid effects of amiodarone: clinical update.胺碘酮的甲状腺作用:临床更新。
Curr Opin Endocrinol Diabetes Obes. 2020 Oct;27(5):329-334. doi: 10.1097/MED.0000000000000562.
2
The effects of amiodarone on the thyroid.胺碘酮对甲状腺的影响。
Endocr Rev. 2001 Apr;22(2):240-54. doi: 10.1210/edrv.22.2.0427.
3
Amiodarone-induced thyroid dysfunction in clinical practice.临床实践中胺碘酮所致的甲状腺功能障碍
Eur Rev Med Pharmacol Sci. 2006 Sep-Oct;10(5):269-78.
4
[Amiodarone and the thyroid gland].[胺碘酮与甲状腺]
Postepy Hig Med Dosw (Online). 2004 Apr 20;58:216-25.
5
Approach to the patient with amiodarone-induced thyrotoxicosis.胺碘酮相关性甲状腺毒症患者的处理方法。
J Clin Endocrinol Metab. 2010 Jun;95(6):2529-35. doi: 10.1210/jc.2010-0180.
6
[Amiodarone-induced thyrotoxicosis].[胺碘酮所致甲状腺毒症]
G Ital Cardiol (Rome). 2017 Mar;18(3):219-229. doi: 10.1714/2674.27399.
7
Amiodarone-induced thyroid dysfunction.胺碘酮所致的甲状腺功能障碍。
J Intensive Care Med. 2015 May;30(4):179-85. doi: 10.1177/0885066613503278. Epub 2013 Sep 24.
8
Effects of amiodarone on thyroid function.胺碘酮对甲状腺功能的影响。
Ann Intern Med. 1997 Jan 1;126(1):63-73. doi: 10.7326/0003-4819-126-1-199701010-00009.
9
[Thyroid and treatment with amiodarone diagnosis, therapy and clinical management].[甲状腺与胺碘酮治疗:诊断、治疗及临床管理]
Wien Med Wochenschr. 2008;158(1-2):29-35. doi: 10.1007/s10354-007-0475-x.
10
Amiodarone therapy: don't forget thyroid.胺碘酮治疗:勿忘甲状腺。
J Pak Med Assoc. 2012 Mar;62(3):268-72.

引用本文的文献

1
Total thyroidectomy performed under general anesthesia with venovenous extracorporeal membrane oxygenation during a thyroid storm: a case report.在甲状腺危象期间,在静脉-静脉体外膜肺氧合辅助下全身麻醉下行甲状腺全切除术:一例报告
J Cardiothorac Surg. 2025 Jun 25;20(1):273. doi: 10.1186/s13019-025-03491-x.
2
Automated Process for Monitoring of Amiodarone Treatment: Development and Evaluation.胺碘酮治疗监测的自动化流程:开发与评估
J Med Internet Res. 2025 Feb 19;27:e65473. doi: 10.2196/65473.
3
Amiodarone Therapy: Updated Practical Insights.
胺碘酮治疗:最新实用见解
J Clin Med. 2024 Oct 12;13(20):6094. doi: 10.3390/jcm13206094.
4
Insights into the prospects of nanobiomaterials in the treatment of cardiac arrhythmia.纳米生物材料在治疗心律失常方面的前景展望。
J Nanobiotechnology. 2024 Aug 30;22(1):523. doi: 10.1186/s12951-024-02805-w.
5
[Type 2 amiodarone-induced thyrotoxicosis: prevalence, time and predictors of development].[2型胺碘酮所致甲状腺毒症:发生率、发病时间及预测因素]
Probl Endokrinol (Mosk). 2023 Oct 23;70(3):9-22. doi: 10.14341/probl13348.
6
Nano drugs delivery system: A novel promise for the treatment of atrial fibrillation.纳米药物递送系统:治疗心房颤动的新希望。
Front Cardiovasc Med. 2022 Oct 26;9:906350. doi: 10.3389/fcvm.2022.906350. eCollection 2022.
7
Protective Role of Amiodarone on Reperfusion Arrhythmia in Patients of Acute Myocardial Infarction with Percutaneous Coronary Intervention Treatment.胺碘酮对急性心肌梗死行经皮冠状动脉介入治疗患者再灌注心律失常的保护作用
Evid Based Complement Alternat Med. 2022 Aug 26;2022:2597173. doi: 10.1155/2022/2597173. eCollection 2022.